As of Oct 12
| +2.58 / +10.03%|
The 7 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 55.00, with a high estimate of 58.00 and a low estimate of 47.00. The median estimate represents a +94.35% increase from the last price of 28.30.
The current consensus among 7 polled investment analysts is to Buy stock in Heron Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.